Trials / Recruiting
RecruitingNCT07293923
Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock
Clinical Feasibility Study of the Magenta Elevate™ Percutaneous Left Ventricular Assist Device (pLVAD) System in Patients With Cardiogenic Shock
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Magenta Medical Ltd. · Industry
- Sex
- All
- Age
- 40 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.
Detailed description
The Elevate™ CS Clinical Feasibility Study is planned as a prospective, single-arm, interventional study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Elevate™ System | The Elevate™ percutaneous Left Ventricular Assist Device System |
Timeline
- Start date
- 2025-11-05
- Primary completion
- 2026-05-30
- Completion
- 2026-10-30
- First posted
- 2025-12-19
- Last updated
- 2026-02-27
Locations
5 sites across 2 countries: Georgia, Israel
Source: ClinicalTrials.gov record NCT07293923. Inclusion in this directory is not an endorsement.